Accumulation of amyloid-b (Ab) is a hallmark of Alzheimer's disease, a neurodegenerative disorder in which synapse loss and dysfunction are early features. Acute exposure of hippocampal slices to Ab leads to changes in synaptic plasticity, specifically reduced long-term potentiation (LTP) and enhanced long-term depression (LTD), with no change in basal synaptic transmission. We also report here that D-AP5, a non-selective NMDA receptor antagonist, completely prevented Ab-mediated inhibition of LTP in area CA1 of the hippocampus. Ro25-6981, an antagonist selective for GluN2B (NR2B) NMDA receptors, only partially prevented this Ab action, suggesting that GluN2A and GluN2B receptors may both contribute to Ab suppression of LTP. The effect of Ab on LTP was also examined in hippocampal slices from BAX 2/2 mice and wild-type littermates. Ab failed to block LTP in hippocampal slices from BAX 2/2 mice, indicating that BAX is essential for Ab inhibition of LTP.
D
espite much evidence for a central role of amyloid-beta (Ab) in the pathogenesis of Alzheimer's disease, the mechanism(s) by which Ab produces structural and functional synaptic deficits remain unclear. NMDA receptors are thought to be essential for a number of Ab-induced defects in synaptic structure, including degradation of key synaptic proteins, disassembly of the postsynaptic density, and synapse loss [1] [2] [3] [4] . However, the role of NMDA receptors in Ab-induced changes in functional synaptic plasticity is less clear.
NMDA receptors are heterotetramers made up of two GluN1 (also known as NR1) subunits and two GluN2 (NR2) subunits. GluN2A and GluN2B are the primary NR2 subunits in the hippocampus. A number of recent in vitro studies [5] [6] [7] have examined the role of GluN2B receptors in Ab impairment of LTP and reported that GluN2B antagonists prevent disruption of LTP by Ab. In the current study, however, we observed only partial attenuation of the Ab effect on LTP with Ro25-6981, a GluN2B-selective antagonist. We also treated hippocampal slices with Ab in the presence of D-AP5, a broad-spectrum NMDA receptor antagonist. D-AP5 prevented the Ab-induced loss of LTP, consistent with results on spine structural plasticity 8 . Thus, our data suggest that both GluN2A and GluN2B can contribute to Ab inhibition of LTP.
Emerging evidence indicates that the molecular pathways that classically mediate programmed cell death (apoptosis) can also participate in non-apoptotic functions in neurons, including synaptic plasticity 9, 10 . In particular, caspase-3 activation has been shown to be required for hippocampal long-term depression (LTD) 11 and for Ab inhibition of hippocampal long-term potentiation (LTP) 12 . BAX, a pro-apoptotic member of the Bcl-2 protein family that is upstream of caspase-3 in the intrinsic (mitochondrial) pathway of apoptosis 13 , is also required for NMDA receptor-dependent LTD in hippocampal neurons 14 . Is BAX also essential for Ab suppression of LTP? We report results in BAX knockout mice that support the conclusion that a common apoptotic pathway is utilized for LTD and Ab suppression of LTP.
Results
Effects of Ab on synaptic transmission and plasticity in area CA1 of the hippocampus. To determine whether Ab affects basal excitatory synaptic transmission, input-output curves were recorded from area CA1 of acute hippocampal slices preincubated with Ab (500 nM, 2 -3 hours) and untreated control slices. A comparison of the two curves reveals no significant difference in basal synaptic transmission following 2-3 hours of Ab pretreatment ( Figure 1A) . Similarly, there was no difference in paired pulse facilitation between Ab-treated slices and untreated slices ( Figure 1B) .
The effect of Ab on synaptic plasticity was also assessed in hippocampal slices. Long-term depression (LTD), induced by 1 Hz stimulation for 15 minutes, was similar in Ab-treated and untreated slices (,20% reduction from baseline; Figure 1C) . However, when a subthreshold LTD induction protocol was used (1 Hz for 5 min rather than 15 min), LTD averaged ,25% in Ab-treated slices but was absent in untreated slices ( Figure 1D ), consistent with recent reports 4, 15 . To measure LTP, we applied theta burst stimulation (TBS; 10 bursts at 5 Hz; burst55 pulses, 100 Hz) after a stable 10-minute baseline period. TBS-induced LTP averaged 122 6 7% (n56) of baseline in untreated hippocampal slices but was abolished in Ab-treated slices (100 6 6%; n56; Figure 1E ). Because picrotoxin (100 mM) was present during the Ab preincubation period in these experiments, it appears that Ab-inhibition of LTP does not reflect excess GABAergic transmission. In sum, exposure to Ab for 2-3 hours enhances LTD and impairs LTP, without affecting basal synaptic transmission.
NMDA receptors are essential for Ab-inhibition of LTP. To test the involvement of NMDA receptors in Ab-mediated suppression of LTP, we added the broad-spectrum NMDA receptor antagonist D-AP5 during the Ab incubation period, and washed it out for 30 min prior to TBS stimulation (because NMDA receptors are essential for LTP induction). In the presence of D-AP5 (50 mM), Ab failed to block LTP (124 6 5%; n56; Figure 2A ). In the same series of experiments, LTP was completely abolished in slices preincubated with Ab alone (102 6 5%; n54). As expected, a two-hour preincubation with D-AP5 alone (followed by a 30 min washout period before LTP induction) had no effect on LTP (127 6 7%; n54; Figure 2B ). Thus, NMDA receptor activity is required during the Ab treatment period for suppression of LTP.
The great majority of NMDA receptors in hippocampus are composed of GluN1 subunits combined with either GluN2A or GluN2B subunits. Which subtype of NMDA receptor is required for the Ab inhibition of LTP? Ro25-6981 (3 mM), a selective GluN2B receptor antagonist, partially attenuated Ab inhibition of LTP when present during the Ab incubation (120 6 7% (n511) vs. 134 6 8% (n510) in untreated controls; Figure 3A ). LTP was not affected by a 2 h preincubation with Ro25-6981 followed by a 30 min washout period before LTP induction (135 6 7%; n54; Figure 3B ). Ro25-6981 did not reverse Ab-inhibition of LTP when applied during the LTP induction protocol (i.e. following Ab incubation; 104 6 4%; n55; Figure 3C ), as opposed to during the Ab preincubation period. Thus GluN2B NMDA receptors are not required for LTP induction; on the contrary, their activity seems to contribute in part to suppression of LTP by Ab.
Ab fails to inhibit LTP in hippocampal slices from BAX 2/2 mice. Caspase-3 knockout mice do not show NMDA receptor dependent LTD or Ab suppression of LTP 11, 12 . Knockout mice lacking BAX, a protein upstream in the mitochondrial pathway of apoptosis, lack LTD in hippocampus 14 . Are these mice also protected from Ab suppression of LTP? We found that CA1 LTP is similar in hippocampal slices from BAX 2/2 and 1/1 littermates (121 6 4% vs. 130 6 4%, n512 and 9, respectively; P50.25; Figure 4 ). As expected, LTP was significantly reduced following Ab pretreatment of BAX 1/1 slices (112 6 8; n55; Figure 4A ). In hippocampal slices from BAX 2/2 littermates, however, LTP was unaffected by Ab (122 6 5; n58; Figure 4B ). Thus, BAX is required for Ab inhibition of LTP, as it is for LTD.
Discussion
We find that Ab inhibits LTP and enhances LTD without disrupting basal synaptic transmission. Because D-AP5 2 when coapplied with Ab 2 largely blocks Ab inhibition of LTP, we conclude that NMDA receptor activity is critical for Ab's ability to suppress LTP. Attenuation of Ab inhibition of LTP by the GluN2B (NR2B)-selective antagonist Ro25-6981 has been reported in vivo 16 and in vitro in hippocampal slices from 6-week to 4-month-old mice [5] [6] [7] . In the current study, LTP was only partially rescued when hippocampal slices from 4-to 5-week-old mice were incubated with Ro25-6981 together with Ab. During postnatal development, the GluN2 subunit composition of NMDA receptors progressively changes from GluN2B to GluN2A [17] [18] [19] . This developmental 'switch' could account for the more subtle Ro25-6981 effect we observe in younger slices. However, if anything, the somewhat less mature hippocampal slices that were used in the current study should have more GluN2B subunits and, thus, should be more sensitive to Ro25-6981. Therefore, our results suggest that NMDA receptors insensitive to Ro25-6981 (possibly GluN2A-containing NMDA receptors) may also contribute to suppression of LTP by Ab.
Ab can directly activate recombinant GluN2A and GluN2B receptors in heterologous expression systems 20 . Ab may act similarly in neurons, though evidence for such direct action is lacking. Ab may promote synaptic glutamate release 21, 22 or impair glutamate reuptake 23, 24 , which indirectly leads to aberrant NMDA receptor activation, especially of extrasynaptic GluN2B NMDA receptors 15 . Ab has also been shown to cause synaptotoxic stimulation of metabotropic glutamate receptors (mGluR5) 25 , which can functionally interact with NMDA receptors.
How might aberrant NMDA receptor activation by Ab lead to impairment of LTP? Recent evidence has pointed to the mitochondrial apoptosis pathway as being critical for NMDA receptordependent LTD and there are emerging mechanistic links between LTD and Ab-mediated suppression of synaptic function 11, 12, 14, 26, 27 . We found that knockout mice lacking BAX -a Bcl2 family protein required for mitochondrial membrane permeabilization and the intrinsic apoptosis pathway -no longer show Ab suppression of LTP, while LTP per se is normal. Together with recent findings that NMDA receptor stimulation leads to significant activation of the caspase-3 cascade 11, 14 , our data provide additional compelling evidence that the mitochondrial pathway of apoptosis is centrally involved in the synaptotoxic action of Ab.
Overactivation of NMDA receptors is often associated with excitotoxic cell death and synaptic depression 28 . However, we observed that acute Ab treatment disrupts LTP in a NMDA receptordependent fashion in the absence of cell death or even weakening of basal synaptic transmission. BAX activation of caspase-3 has been linked to non-apoptotic functions in addition to programmed cell death 13, 14 . Analogous to caspase-3 11, 12 , BAX plays a role in LTD induction 14 and Ab-inhibition of LTP (Figure 4) . Thus, mediators classically associated with apoptosis may play critical non-apoptotic roles in the pathophysiology of Alzheimer's disease, and as such, may serve as potential therapeutic targets in this and other neurodegenerative diseases.
The molecular mechanisms by which activation of the apoptotic pathway and caspase-3 lead to synaptic dysfunction remain unclear. Intriguing data suggest that tau -a protein highly implicated in the pathology of Alzheimer's disease and other neurodegenerative disorders 29 -is required for impaired LTP in mouse models of Alzheimer's disease 30 and Ab-treated hippocampal slices 31 . Caspase-3 can cleave tau at a specific site, which promotes tau aggregation 32, 33 . Accumulation of dendritic tau may favor the interaction between PSD-95 and NMDA receptors, thereby promoting excitotoxicity 34 . Whether such a mechanism mutually links NMDA receptors and the apoptotic cascade, and whether this mechanism contributes to Ab impairment of LTP, remains to be elucidated. Methods Electrophysiology. Transverse hippocampal slices (400 mm thick) were prepared from 2-to 3-week-old mice for LTD experiments and 4-to 5-week old mice for all other experiments. Slices were cut in artificial cerebrospinal fluid (ACSF), which contained (in mM): 119 NaCl, 2.5 KCl, 1.3 MgSO 4 , 2.5 CaCl 2 , 1 NaH 2 PO 4 , 26 NaHCO 3 and 11 glucose, equilibrated with 95% 0 2 /5% CO 2 . Slices were allowed to recover in ACSF for 45 min at 37uC followed by $1-hour incubation at room temperature. Following the recovery period, slices were incubated with Ab (500 nM) or Ab 1 NMDA receptor antagonist. Two to three hours later, slices were transferred to a submerged recording chamber mounted on an Olympus dissecting microscope. Untreated control slices or slices treated with NMDA receptor antagonist were interleaved with Ab-treated slices. For experiments with BAX 2/2 mice, slices from BAX 1/1 littermates were interleaved.
A glass pipette filled with ACSF was used to stimulate the Schaffer collaterals and field excitatory postsynaptic potentials (fEPSPs) were recorded extracellularly in area CA1 at room temperature using low-resistance patch pipettes filled with ACSF. The baseline stimulation rate was 0.05 Hz. fEPSPs were filtered at 2 kHz and digitized at 10 kHz with a Multiclamp (Molecular Devices, Sunnyvale, CA). Data were collected and analyzed with pClamp 10.2.0.12 software (Molecular Devices). Fiber volley amplitude was measured peak-to-peak. The slope of the initial rising phase (20-60% of the peak amplitude) of the fEPSP was used as a measure of the postsynaptic response. All data are expressed as mean 6 SEM. Student's t-test and one-way ANOVA were used to measure statistical significance. P#0.05 was considered significant.
BAX null mice. BAX knockout mice were obtained from Stanley Korsemeyer 35 and were bred/maintained at Genentech in accordance with the guidelines set forth by our Institutional Animal Care and Use Committee.
Reagents. Soluble oligomeric Ab 1-42 (mostly ranging from 2-mer to 6-mer 12 ) was prepared according to the manufacturer's instructions (Ascent Scientific, Princeton, NJ). Briefly, Ab (1 mg/ml) was dissolved in 1, 1, 1, 3, 3, 3 -hexafluoro-2-propanol (HFIP; Sigma, St. Louis, MO), incubated at room temperature for 1 hr with occasional vortexing, and then sonicated for 10 min. The solution was dried under a gentle stream of nitrogen gas, then resuspended in 100% DMSO and incubated for 12 min at room temperature. This Ab stock solution was aliquoted and stored at -80uC. On each experimental day, an aliquot of Ab stock solution was diluted to 500 nM with D-PBS (Invitrogen, Carlsbad, CA) and incubated for 2 hr at room temperature to permit peptide aggregation.
The following drugs, prepared daily from concentrated ($ 1000 3) stock solutions, were also used in this study: picrotoxin (Tocris, Ellisville, MO), D-AP5 (Tocris) and Ro25-6981 (synthesized in-house).
